* Phibro Animal Health Corp PAHC.OQ reported quarterly
adjusted
earnings of 54 cents per share for the quarter ended December
31, higher than the same quarter last year, when the company
reported EPS of 33 cents. The mean expectation of four analysts
for the quarter was for earnings of 43 cents per share. Wall
Street expected results to range from 34 cents to 48 cents per
share.
* Revenue rose 23.8% to $309.30 million from a year ago;
analysts
expected $303.84 million.
* Phibro Animal Health Corp's reported EPS for the quarter
was 8
cents.
* The company reported quarterly net income of $3.2 million.
* Phibro Animal Health Corp shares had risen by 4.9% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 5.1%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "sell"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and 3 "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "sell"
Wall Street's median 12-month price target for Phibro Animal
Health Corp is $20.50
This summary was machine generated from LSEG data February 6 at
12:18 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 0.43 0.54 Beat
Sep. 30 2024 0.25 0.35 Beat
Jun. 30 2024 0.33 0.41 Beat
Mar. 31 2024 0.29 0.31 Beat